The global In Vitro Diagnostics Market is projected to be valued at USD 108.3 billion in 2024 and reach USD 150.13 billion by ...

Nordic Bioscience introduces nordicEndotrophin™, a fully automated high-precision assay that selectively quantifies the ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

Roche’s Herceptin and Perjeta duo is already part of a well-established standard of care in early-stage HER2-positive breast cancer. Now, the company can further back up the regimen’s prowess ...

INDIANAPOLIS, May 12, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today it plans to invest up to $550 million in its Diagnostics site in Indianapolis by 2030. The site will ...

About a month after disclosing a $50 billion investment in its U.S. operations, Roche is beginning to peel back the layers on its plans, starting with a new manufacturing facility in the Tar Heel ...

The global ASEAN Point of Care Diagnostics Market, valued at US$1.05 billion in 2024, is forecasted to grow at a robust CAGR ...

May 12 (Reuters) - Roche Group (ROG.S), opens new tab said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to ...

Genentech, a biotechnology company and member of the Roche Group, announced on May 12, 2025, that it will invest more than $700 million in a new, state-of-the-art drug manufacturing facility in Holly ...

(Reuters) -Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to expand its presence in the ...